Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease

Neurochemistry International

Volumn 45, Issue 1, 2004, Pages 57-62

  Ryberg, Henrik ^a   Söderling, Ann Sofi ^a   Davidsson, Pia ^a   Blennow, Kaj ^a   Caidahl, Kenneth ^a   Persson, Lennart I ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gas chromatography (GC); Mass spectrometry (MS); Motor neuron disease; Neurodegeneration; Oxidative stress

Indexed keywords

3 NITROTYROSINE; AMINO ACID DERIVATIVE; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOLOGICAL MONITORING; CELL DAMAGE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; MOLECULAR MECHANICS; OXIDATION; OXIDATIVE STRESS; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; TYROSINE;

EID: 1842788079     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2003.12.012     Document Type: Article

References (44)

1. Abe K., Pan L.H., Watanabe M., Kato T., Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199:1995;152-154.
2. Althaus J.S., Schmidt K.R., Fountain S.T., Tseng M.T., Carroll R.T., Galatsis P., Hall E.D. LC-MS-MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels. Free Radic. Biol. Med. 29:2000;1085-1095.
3. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7162-7166.
4. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial Clinical Limits of Amyotrophic Lateral Sclerosis workshop contributors. J. Neurol. Sci. 124(Suppl.):1994;96-107.
5. Castegna A., Thongboonkerd V., Klein J.B., Lynn B., Markesbery W.R., Butterfield D.A. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85:2003;1394-1401.
6. Chou S.M., Wang H.S., Taniguchi A., Bucala R. Advanced glycation end-products in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis. Mol. Med. 4:1998;324-332.
7. Cookson M.R., Ince P.G., Shaw P.J. Peroxynitrite and hydrogen peroxide-induced cell death in the NSC34 neuroblastoma × spinal cord cell line: role of poly(ADP-ribose) polymerase. J. Neurochem. 70:1998;501-508.
8. Crowley J.R., Yarasheski K., Leeuwenburgh C., Turk J., Heinecke J.W. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Anal. Biochem. 259:1998;127-135.
9. Davies K.J. Protein damage and degradation by oxygen radicals. I. General aspects. J. Biol. Chem. 262:1987;9895-9901.
10. Davies M.J., Fu S., Wang H., Dean R.T. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic. Biol. Med. 27:1999;1151-1163.
11. Delatour T., Guy P.A., Stadler R.H., Turesky R.J. 3-Nitrotyrosine butyl ester: a novel derivative to assess tyrosine nitration in rat plasma by liquid chromatography/tandem mass spectrometry detection. Anal. Biochem. 302:2002;10-18.
12. Estevez A.G., Radi R., Barbeito L., Shin J.T., Thompson J.A., Beckman J.S. Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65:1995;1543-1550.
13. Floyd R.A. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 26:1999;1346-1355.
14. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
15. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
16. Heales S.J., Bolanos J.P., Stewart V.C., Brookes P.S., Land J.M., Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta. 1410:1999;215-228.
17. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., Lovell M., Markesbery W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
18. Hensley K., Maidt M.L., Yu Z., Sang H., Markesbery W.R., Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18:1998;8126-8132.
19. Ischiropoulos H., Al-Mehdi A.B. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 364:1995;279-282.
20. Ischiropoulos H., Zhu L., Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:1992;446-451.
21. Jonnala R.R., Buccafusco J.J. Inhibition of nerve growth factor signaling by peroxynitrite. J. Neurosci. Res. 63:2001;27-34.
22. Kaur H., Lyras L., Jenner P., Halliwell B. Artefacts in HPLC detection of 3-nitrotyrosine in human brain tissue. J. Neurochem. 70:1998;2220-2223.
23. Liu D., Ling X., Wen J., Liu J. The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J. Neurochem. 75:2000;2144-2154.
24. MacMillan-Crow L.A., Crow J.P., Thompson J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry. 37:1998;1613-1622.
25. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of the Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
26. Orrell R.W. Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations. Neuromuscul. Disord. 10:2000;63-68.
27. Patel M., Day B.J., Crapo J.D., Fridovich I., McNamara J.O. Requirement for superoxide in excitotoxic cell death. Neuron. 16:1996;345-355.
28. Pennathur S., Jackson-Lewis V., Przedborski S., Heinecke J.W. Mass spectrometric quantification of 3-nitrotyrosine, o-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J. Biol. Chem. 274:1999;34621-34628.
29. Petersson A.-S., Steen H., Kalume D.E., Caidahl K., Roepstorff P. Investigation of tyrosine nitration in proteins by mass spectrometry. J. Mass Spectrom. 36:2001;616-625.
30. Rolland B., Le Prince G., Fages C., Nunez J., Tardy M. GFAP turnover during astroglial proliferation and differentiation. Brain Res. Dev. Brain Res. 56:1990;144-149.
31. Sayre L.M., Perry G., Smith M.A. Redox metals and neurodegenerative disease. Curr. Opin. Chem. Biol. 3:1999;220-225.
32. Shaw P.J., Ince P.G., Falkous G., Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol. 38:1995;691-695.
33. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's disease. Nature. 382:1996;120-121.
34. Sokolovsky M., Riordan J.F., Vallee B.L. Tetranitromethane: a reagent for the nitration of tyrosyl residues in proteins. Biochemistry. 5:1966;3582-3589.
35. Söderling A.-S., Ryberg H., Gabrielsson A., Lärstad M., Torén K., Niari S., Caidahl K. A derivatization assay using gas chromatography/negative chemical ionization tandem mass spectrometry to quantify 3-nitrotyrosine in human plasma. J. Mass Spectrom. 38:2003;1187-1196.
36. Strong M.J., Sopper M.M., Crow J.P., Strong W.L., Beckman J.S. Nitration of the low molecular weight neurofilament is equivalent in sporadic amyotrophic lateral sclerosis and control cervical spinal cord. Biochem. Biophys. Res. Commun. 248:1998;157-164.
37. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol. 46:1999a;129-131.
38. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci. Lett. 269:1999b;52-54.
39. Torreilles F., Salman-Tabcheh S., Guerin M., Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Brain Res. Rev. 30:1999;153-163.
40. Tsikas D., Schwedhelm E., Frölich J.C. Methodological considerations on the detection of 3-nitrotyrosine in the cardiovascular system. Circ. Res. 90:2002;E70.
41. Tsikas D., Schwedhelm E., Stutzer F.K., Gutzki F.-M., Rode I., Mehls C., Frölich J.C. Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry. J. Chromatogr. B. 784:2003;77-90.
42. Waggoner D.J., Bartnikas T.B., Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol. Dis. 6:1999;221-230.
43. Yamakura F., Taka H., Fujimura T., Murayama K. Inactivation of human manganese superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J. Biol. Chem. 273:1998;14085-14089.
44. Yi D., Ingelse B.A., Duncan M.W., Smythe G.A. Quantification of 3-nitrotyrosine in biological tissues and fluids: generating valid results by eliminating artifactual formation. J. Am. Soc. Mass Spectrom. 11:2000;578-586.